PNC-28 (20mg)

This research vial contains PNC-28, a synthetic peptide studied for its potential anti-tumor properties through targeted disruption of MDM2–p53 interactions. Researchers have explored PNC-28 for its effects on inducing apoptosis in cancer cells and enhancing p53 activity in preclinical cancer models.

Blend Composition (Per Vial):
PNC-28 – 20mg

Key Characteristics:

• PNC-28: Synthetic peptide studied for tumor suppression via p53 activation

• Investigated for apoptosis induction and selective cancer cell cytotoxicity

• Sterile vial format supports stability and controlled reconstitution

• Stable composition optimized for reproducibility in oncology-related research

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.